STOCKWATCH
·
Pharmaceuticals
Quarterly Result3 Apr 2025, 03:17 pm

Wanbury Ltd. Achieves Highest Quarterly Revenues in Q4 & Improved Margins Amidst US-China Trade War

AI Summary

Wanbury Ltd. has announced improved capacity utilization for Q4, leading to the highest quarterly revenues and improved margins. The company has achieved this through plant upgradation and engagement of external technical experts for process improvement and cost efficiencies. The pharmaceutical sector in India has temporarily dodged the US tariff hikes, which is good news for the industry. The company has clarified that no UPSI will be shared during the plant visit.

Key Highlights

  • Wanbury Ltd. achieves highest quarterly revenues for Q4 and improved margins.
  • Company has improved capacity utilization through plant upgradation.
  • Engaged external technical experts to improve profitability via improvement in yield, process improvement & efficiencies.
  • Pharmaceutical sector in India temporarily spared from US tariff hikes.
  • Company clarifies no UPSI will be shared during the plant visit.
WANBURY
Pharmaceuticals
WANBURY LTD.

Price Impact